Singular Genomics Systems, Inc. (OMIC)
NASDAQ: OMIC · IEX Real-Time Price · USD
0.381
+0.010 (2.72%)
May 17, 2024, 4:30 PM EDT - Market closed

Singular Genomics Systems Revenue

Singular Genomics Systems had revenue of $2.49M in the twelve months ending March 31, 2024, with 52.95% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $442.00K, a -48.78% decrease year-over-year. In the year 2023, Singular Genomics Systems had annual revenue of $2.91M with 280.52% growth.

Revenue (ttm)
$2.49M
Revenue Growth
+52.95%
P/S Ratio
11.60
Revenue / Employee
$9,765
Employees
255
Market Cap
28.89M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.91M2.15M280.52%
Dec 31, 2022765.00K--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spectral AI 19.30M
DURECT 8.32M
Oncternal Therapeutics 1.15M
Femasys 1.05M
Biora Therapeutics 544.00K
Revenue Rankings